Warning: The NCBI web site requires JavaScript to function. more...
Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis.
Haselow NJ, Akame J, Evini C, Akongo S.
Filaria J. 2003 Oct 24;2 Suppl 1:S10.
Related citations
Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
Gardon J, Gardon-Wendel N, Demanga-Ngangue, Kamgno J, Chippaux JP, Boussinesq M.
Lancet. 1997 Jul 5;350(9070):18-22.
The Mectizan Donation Program (MDP).
Thylefors B.
Ann Trop Med Parasitol. 2008 Sep;102 Suppl 1:39-44.
Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis.
Twum-Danso NA, Meredith SE.
Trop Med Int Health. 2003 Sep;8(9):820-31.
Report of a Scientific Working Group on Serious Adverse Events following Mectizan(R) treatment of onchocerciasis in Loa loa endemic areas.
Scientific Working Group on Serious Adverse Events in Loa Loa endemic areas.
Filaria J. 2003 Oct 24;2 Suppl 1:S2.
Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon.
Wanji S, Tendongfor N, Esum M, Yundze SS, Taylor MJ, Enyong P.
Filaria J. 2005 Apr 7;4(1):2.
Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon.
Wanji S, Tendongfor N, Nji T, Esum M, Che JN, Nkwescheu A, Alassa F, Kamnang G, Enyong PA, Taylor MJ, Hoerauf A, Taylor DW.
Parasit Vectors. 2009 Aug 27;2(1):39.
Adverse reactions from community directed treatment with ivermectin (CDTI) for onchocerciasis and loiasis in Ondo State, Nigeria.
Otubanjo OA, Adeoye GO, Ibidapo CA, Akinsanya B, Okeke P, Atalabi T, Adejai ET, Braide E.
Rev Biol Trop. 2008 Dec;56(4):1635-43.
Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa.
Pion DS, Gardon J, Kamgno J, Gardon-Wendel N, Chippaux JP, Boussinesq M.
Parasitology. 2004 Nov;129(Pt 5):613-26.
Integrated rapid mapping of onchocerciasis and loiasis in the Democratic Republic of Congo: impact on control strategies.
Tekle AH, Zoure H, Wanji S, Leak S, Noma M, Remme JH, Amazigo U.
Acta Trop. 2011 Sep;120 Suppl 1:S81-90. Epub 2010 Jun 4.
Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin.
Esum M, Wanji S, Tendongfor N, Enyong P.
Trans R Soc Trop Med Hyg. 2001 Nov-Dec;95(6):673-6.
Control of onchocerciasis.
Boatin BA, Richards FO Jr.
Adv Parasitol. 2006;61:349-94. Review.
Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases.
Twum-Danso NA.
Filaria J. 2003 Oct 24;2 Suppl 1:S3.
Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis.
Boussinesq M, Gardon J, Gardon-Wendel N, Kamgno J, Ngoumou P, Chippaux JP.
Am J Trop Med Hyg. 1998 Apr;58(4):461-9.
Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications.
Pion SD, Filipe JA, Kamgno J, Gardon J, Basáñez MG, Boussinesq M.
Parasitology. 2006 Jul;133(Pt 1):101-9.
Onchocerciasis control in Uganda: how can self-sustaining, community-based treatment with ivermectin be achieved?
Mutabazi D, Duke BO.
Ann Trop Med Parasitol. 1998 Mar;92(2):195-203.
APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations. African Programme for Onchocerciasis Control.
Homeida M, Braide E, Elhassan E, Amazigo UV, Liese B, Benton B, Noma M, Etya'alé D, Dadzie KY, Kale OO, Sékétéli A.
Ann Trop Med Parasitol. 2002 Mar;96 Suppl 1:S93-104.
Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis.
Thylefors B, Alleman MM, Twum-Danso NA.
Trop Med Int Health. 2008 May;13(5):689-96. Review.
Effect of repeated community-based ivermectin treatment on the intensity of onchocerciasis in Nigeria.
Oyibo WA, Fagbenro-Beyioku AF.
Rural Remote Health. 2003 Jul-Sep;3(2):211. Epub 2003 Sep 6.
Integrated community-directed treatment for the control of onchocerciasis, schistosomiasis and intestinal helminths infections in Uganda: advantages and disadvantages.
Ndyomugyenyi R, Kabatereine N.
Trop Med Int Health. 2003 Nov;8(11):997-1004.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on